Impella 5.5 Direct Aortic Implant and Explant Techniques

The Impella 5.5 with SmartAssist system (Abiomed, Danvers, MA) is approved for the treatment of cardiogenic shock after acute myocardial infarction, cardiac surgery, or in the setting of cardiomyopathy. Designed for full circulatory support and left ventricular unloading the system comprises a cathe...

Full description

Saved in:
Bibliographic Details
Published inThe Annals of thoracic surgery Vol. 111; no. 5; pp. e373 - e375
Main Authors Anderson, Mark, Smith, Deane, Kane, Peter, Lee, Raymond, Khalpey, Zain, Williams, Jason
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.05.2021
Online AccessGet full text

Cover

More Information
Summary:The Impella 5.5 with SmartAssist system (Abiomed, Danvers, MA) is approved for the treatment of cardiogenic shock after acute myocardial infarction, cardiac surgery, or in the setting of cardiomyopathy. Designed for full circulatory support and left ventricular unloading the system comprises a catheter-based microaxial pump placed across the aortic valve, pulling blood from the left ventricle and into the ascending aorta. Implantation can be approached through the axillary artery or directly into the aortic root. We present several technical options for implanting, tunneling, and explanting the system using the direct aortic approach and allowing for bedside removal.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Technical Report-1
ObjectType-Feature-3
content type line 23
ISSN:0003-4975
1552-6259
DOI:10.1016/j.athoracsur.2020.09.069